WASHINGTON, D.C. — AACR President-elect Judy E. Garber, M.D., M.P.H., testified on Sept. 22 before the President’s Cancer Panel, “The Future of Cancer Research: Accelerating Scientific Innovation.” The panel is exploring progress achieved since the National Cancer Act of 1971, and envisioning the course of cancer research in the coming decades.
In her testimony, Garber discussed the future applications of personalized cancer medicine, and the paradigm shift from classifying cancer based on organ site to examining the disease based on its genetic mutation, in order to identify the most appropriate drugs for each patient. She emphasized the importance of increased funding for groundbreaking basic, translational and clinical cancer research, and investing in the next generation of cancer researchers.
The President’s Cancer Panel, established in 1971, monitors the development and execution of the National Cancer Program and submits periodic progress reports. Additionally, the panel annually evaluates the efficacy of the program and makes suggestions for improvements.
Listen to Dr. Garber discuss the challenges of cancer research and the goals of her upcoming presidency at the AACR.
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 32,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowship and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.